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PAIN SENSITIVITY: SEX DIFFERENCES, GENETICS AND THE ASSOCIATION
WITH CHRONIC JOINT PAIN
M. de Kruijf, M.J. Peters, A. Hofman, F. Rivadeneira, S.M. Bierma-
Zeinstra, F.J. Huijgen, A.G. Uitterlinden, J.B. van Meurs. Erasmus MC,
Rotterdam, Netherlands
Purpose: Chronic musculoskeletal pain (CMP) is very common in the
population, with osteoarthritis being the most eminent underlying
disease. The aetiology of CMP is complex with both genetics and envi-
ronment playing a role. One of the characteristics determining the
development of CMP is a person's sensitivity to pain. We therefore aim to
elucidate the determinants of pain sensitivity in the general population
and in chronic pain.
Methods: Until the summer of 2011, for 754 participants of the Rotterdam
Study, pain sensitivity was determined by measuring heat pain thresholds
using a thermo-sensory analyzer (TSA II, Medoc Advanced Medical
Systems, Durham, NC). Forty-ﬁve participants were excluded due to
personal or technical problemswith the test. Participants completed a pain
homunculus, inwhich they draw circles around joints where they had pain
for more than half of the days, in the last six weeks. Cox regression was
used to evaluate the relationship between heat pain thresholds and
baseline characteristics (age, gender, BMI), and the associationwith having
chronic pain in more than 2 joints in a case-control setting. In an extensive
literature search, we found 44 previously described genes of which 136
single nucleotide polymorphisms (SNPs) were possibly associated with
pain phenotypes. Using linear regression, we tested the association
between these SNPs and the heat pain thresholds in 558 participants for
which genetic data was available.
Results: In the 709 participants, the mean age was 71.7 (65.9-92.9), 52.9%
was female. Themeanpain threshold ofwomenwas on average 2.0oC lower
compared tomen (p¼1.7x10-14). Heat pain thresholdwas not related to age
or BMI. Whenwe compared participants without joint pain and those with
pain inmore than 2 joints, we observed that the participantswith pain have
an on average 1.3 oC higher mean pain threshold temperature (p¼0.03). Of
the 44 candidate gene loci, the SNP rs8192619 in the TAAR1 gene (trace
amine associated receptor 1) at chromosome 6 was the most associated
with the pain threshold temperature (p¼0.02). Carriers of the minor A-
allele (frequency: 5%) had 1.1oC lower mean heat pain threshold. This
ﬁnding is in line with the corresponding literature, in which the minor A-
allele was associated with a higher risk for ﬁbromyalgia.
Conclusions: We found a difference in pain sensitivity between sexes,
with females being more sensitive to pain. We demonstrated that the
mean pain threshold is higher in persons suffering from chronic joint pain,
indicating the activation of the pain inhibitory mechanisms in these
individuals. We found genetic variation in the TAAR1 gene to be associated
with pain sensitivity. This is an interesting locus because it encodes
a receptor that regulates monoamine levels in the brain and is implicated
in the functional regulation of the dopamine system. Heat pain threshold
measurements are still ongoing to increase power. Replication in our own
and other cohorts is needed to verify our ﬁndings.
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THE RELATIONSHIP BETWEEN NEUROPATHIC PAIN SYMPTOMS ON THE
MODIFIED PAIN DETECT AND SIGNS OF CENTRAL SENSITIZATION IN
KNEE OSTEOARTHRITIS
J. Hochman 1, J. Elkayam1, L. Gagliese 2, A. Davis 3, G. Hawker 1. 1Women's
Coll. Hosp., Toronto, ON, Canada; 2Univ. Hlth.Network, Toronto, ON,
Canada; 3 Toronto Western Res. Inst., Toronto, ON, Canada
Purpose: Central sensitization may contribute to pain in a subset of people
with knee OA and present with a distinct clinical phenotype including
neuropathic-like symptoms and sensory abnormalities. A neuropathic pain
(NP) questionnaire modiﬁed for use in knee OA, the modiﬁed painDETECT
(mPD-Q), may aid the identiﬁcation of central sensitization in this pop-
ulation. The aim of this novel study was to assess the relationship between
mPD-Q scores and signs of central sensitization, assessed using a quanti-
tative sensory testing (QST) protocol, in adults with chronic knee OA.Methods: Eligible participants had chronic, symptomatic, knee OA,
without other pain or neurological conditions. Age and gender matched
reference data was obtained from controls, enabling identiﬁcation of
sensory abnormalities among individual participants. Prior to QST, data
was collected on NP symptoms (mPD-Q) for each knee, sociodemographic
factors, BMI, OA duration and severity (WOMAC), pain intensity (Von Korff
Chronic Pain Grade, CPG, pain intensity subscale), depressive symptoms
(Centre for Epidemiologic Studies Depression Scale, CES-D), and pain
catastrophizing (pain catastrophizing scale, PCS). The standardized/
comprehensive QST protocol, developed by the German Research Network
on Neuropathic Pain (DFNS), was conducted on the medial aspect of all
eligible knees. QST signs of central sensitization were deﬁned as:
mechanical hyperalgesia and/or enhanced temporal summation and /or
allodynia. Abnormal sensation was deﬁned as QST ﬁndings >2 standard
deviations above or below the mean of controls. Generalized estimating
equation modeling was used to examine the relationship between the
presence of central sensitization (yes/no) and mPD-Q scores (above or
below the median) by knees.
Results: The majority of the 36 participants were female (83.3%) and
Caucasian (83.3%), aged (SD) 60.7 (6.8) years, with a high median (min,
max) BMI of 28.2 (19.5, 62.3). Mean (SD) duration of knee symptoms and
time since knee OA diagnosis were 13.6 (13.2) years and 7.4 (10.0) years,
respectively. Mean (SD) severity of OA was moderate: WOMAC total was
38.7/96 (18.5), CPG score was 52.0/100 (19.8). Among the 36 study
participants, 57 knees were painful and eligible for participation. Median
mPD-Q score among all knees was 9 (range 0-33). 45.6% of assessed knees
had  1 sign of central sensitization in order of frequency: mechanical
hyperalgesia (36.8%), enhanced temporal summation (10.5%), and allody-
nia (5.3%). Controlling for age, individuals with higher mPD-Q scores (
the median of 9.0) had a signiﬁcantly higher odds of meeting our criteria
for central sensitization (adjusted OR ¼ 3.85; 95% CI, 1.16-12.7, p ¼0.027).
Additional adjustment for pain catastrophizing, pain intensity, or
depressed mood did not attenuate this relationship.
Conclusions: Among a sample of adults with chronic, painful knee OA,
higher scores on the mPD-Q were associated with greater odds of having
one or more sign of central sensitization on QST. Thus, the mPD-Q may aid
the identiﬁcation of central sensitization in adults with chronic knee OA.
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ANALYSIS OF CIRCULATING IMMUNE COMPLEXES CONTAINING PAIN-
ASSOCIATED MOLECULES IN PATIENTS WITH KNEE OSTEOARTHRITIS:
FROM THE LABORATORY TO THE CLINIC
Y. Savitskaya, L. Ramos, C. Duarte, R. Tellez, E. Estrada, E. Morales, N.
Marin, F. Cruz, A. Almazan, C. Ibarra. Natl. Inst. of Rehabilitation, Mexico,
Mexico
Purpose: Today’s leading laboratory researchers, pharmacy and biotech
decision-makers, technology companies and clinicians are focusing on the
uses of biomarkers in the ﬁeld of osteoarthritis research. Osteoarthritis of
the knee (kOA) has in the past been considered a predominately degen-
erative joint disease, affecting more people than any other arthritis. In kOA
disease, pathogenic pain-associated molecules are used for development
of diagnostic criteria, monitoring of disease activity, and prognosis. As
such, the body has many pain messengers, receptors and neural pathways
to sense that information. Analysis of circulating immune complexes (CICs)
produced during an immune response may be useful in elucidating some
aspects of kOA process. To investigate the presence of immune complexes
containing pain-associated molecules such as interleukin 6 (IL-6), inter-
leukin 18 (IL-18), angiotensin-converting enzyme (ACE), prostaglandin E2
(PGE2) in the peripheral blood sera of kOA patients and to evaluate their
potential as markers of kOA pathogenesis. This knowledge increases he
quality of medicine and surgery.
Methods: Circulating biomarker-Ig immune complexes were measured in
serum samples from 54 patients with kOA and from 54 healthy controls
using a novel ELISA (INR, Mexico). kOA severity as deﬁned by increasing
Kellgren & Lawrence (KL) grade. Pain was measured using a visual
analogue scale (VAS, 0-100 mm). kOA biopsies were obtained at arthros-
copy. Apoptosis was assessed using Caspase-Glo 3/7 assay.
Results:We applied our strategy to the analysis of CICs in kOA patients and
healthy controls. Our technique for CICs analysis uses routine clinical
Spearman rank-correlation coefﬁcients: r (p-value)





PTT - 0.02 (0.79) -0.03 (0.73) -0.02 (0.79)
CRP -0.02 (0.79) 0.02 (0.82) -0.04 (0.64) -
PTT ¼ pressure-pain tolerance thresholdCRP ¼ C-reactive protein
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ing PGE2 and IL-18 were found in the serum of 81% and 65% of kOA
patients. Serum PGE2-IgG and IL-18-IgG are signiﬁcantly higher in the kOA
group than those in the control group (P<0.01). A signiﬁcant positive
correlation was noted between their expressions (r¼0.863, P<0.01). No
correlation between the serum PGE2-IgG and IL-6-IgG was found. Deﬁ-
ciency in the sera ACE-IgM predisposes the expression of high afﬁnity
PGE2-IgG in kOA patients. There was a negative correlation between
serum PGE2-IgG and ACE-IgM in kOA patients (r¼-0.58, P<0.05). No
statistically signiﬁcant differences were found between serum levels of
biomarker-IgM and biomarker-IgA for kOA patients.
Conclusions: Blood still represents an ideal clinical source of markers
because of its known role in reﬂecting systemic changes associated with
disease. Improved analytical methods are required to accommodate the
analysis of large numbers of samples for biological and epidemiological
monitoring. Our method may be generally applicable to the study of the
relationship between CICs and kOA diseases. The ICs in the serum of
a majority of the OA patients contained PGE2 or ACE, and these ICs may
have potential as alternative biomarkers. The role of ACE-IgM and PGE2-
IgG in the modulation of the immune response, pain and inﬂammation has
been regarded as important. The biomarkers in combination (ACE-IgM and
PGE2-IgG) work better.
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THE ASSOCIATION BETWEEN PRESSURE-PAIN TOLERANCE THRESHOLD
AND LOCAL AND/OR SYSTEMIC INFLAMMATION IN OBESE KNEE
OSTEOARTHRITIS PATIENTS: A CROSS-SECTIONAL STUDY.
T.S. Jørgensen 1,2, A. Jespersen 1, R. Christensen 1,3, H. Gudbergsen 1,
T. Graven-Nielsen 2, H. Bliddal 1,2, M. Henriksen 1. 1 Parker Inst.,
Copenhagen, Denmark; 2Ctr. for Sensory-Motor Interaction (SMI), Dept. of
Hlth.Sci. and Technology, Aalborg Univ., Aalborg, Denmark; 3 Inst. of Sports
Sci. and Clinical Biomechanics, Faculty of Hlth.Sci.,Univ. of Southern
Denmark, Odense, Denmark
Purpose: The most prominent manifest of osteoarthritis (OA) is cartilage
loss although, inﬂammation is acknowledged as an important factor that
may also sensitize the pain system. Obesity is strongly associated with
knee OA, and clinical and experimental evidence suggests that obesity is
a low-grade systemic inﬂammatory condition. It is, however, unknown if
the presence of inﬂammation affects the pain sensitivity in obese knee OA
patients. The aim of the study was to investigate whether local and/or
systemic signs of inﬂammation are associated with pain sensitivity in
obese knee OA patients. A secondary aim was to assess the association
between local and systemic signs of inﬂammation.
Methods: Baseline data from a prospective weight loss study (the CAROT
study) including 192 patients were used. Local inﬂammation was assessed
as synovitis scores from a semi-quantitative grading of MRI images using
a comprehensive scoring method, the Boston-Leeds Osteoarthritis Knee
Score (BLOKS): The infrapatellar fat pad size was taken as a marker of local
inﬂammation severity and scored as: 0¼normal; 1¼mild; 2¼moderate;
3¼severe synovitis (Infrapatellar Size Score). Further, the extent of synovitis
onMRIwas scored as presence (yes/no) of synovitis in 5 regions of the knee:
i) infrapatellar fat pad, ii) medial posterior-condylar, iii) lateral posterior-
condylar, iv)medial recess, and v) lateral recess (Synovitis Extent). Systemic
inﬂammation was assessed by serum C-reactive protein - (CRP). For
assessment of pain sensitivity pressure-pain tolerance threshold (PTT) of
the lower leg was assessed using a computerized tourniquet cuff pressure
algometer. When the pressure pain intensity was intolerable patients
pressed a button and the termination pressure deﬁned the PTT (recorded in
kPa). Bivariate Spearman's rank correlation was used to evaluate associa-
tions between PTT and local and systemic signs of inﬂammation.
Results: All the patients included in the trial (192) had CRPmeasurements,
176 had PTT assessments, and 187 underwent MRI. The average PTT was
40.9 kPa (SD 19.9) and the mean CRP was 6.0 mg/L (SD 6.4). The median
infrapatellar fat pad size score was 1 (quartiles 0;1), and the median
number of synovitis sites was 3 (quartiles 2;4). There were no statistical
associations between PTT and the MRI outcomes (P>0.73), nor with CRP
(P¼ 0.79; Table). Neither were CRP and the MRI outcomes statistically
associated (P>0.64; Table).Conclusions: This study does not provide evidence of any association
between local or systemic signs of inﬂammation and pain sensitivity in
obese knee OA patients. There was also no association between local and
systemic indices of inﬂammation in obese knee OA patients.511
PREDICTING DETERMINANTS FOR INCIDENT KNEE PAIN AFTER 2 YEARS
IN MIDDLE-AGED WOMEN: A LONGITUDINAL OSTEOARTHRITIS STUDY
B.M. de Klerk, D. Schiphof, E.H. Oei, H. Weinans, A. Hofman, S.M. Bierma-
Zeinstra. Erasmus Univ. Med. Ctr., Rotterdam, Netherlands
Purpose: Early recognition of knee osteoarthritis (OA) is a problem since
speciﬁc high-risk proﬁles are lacking. Predicting who will develop knee
pain in a later stage is one step in the process of identifying persons at
high-risk of OA development. The aim of this study is to identify prognostic
determinants for new knee pain at two years of follow-up in women of
middle age.
Methods: Data from women between age 45 and 60 of the Rotterdam
Study that were included in an MRI study (n¼ 891) was used if they had at
least one pain-free knee at baseline. Degenerative signs of knee tissues
(MRI), physical examination and history taking data, as well as OA risk
factors were assessed at baseline at the research center; knee pain pres-
ence at two years was assessed using questionnaires. Analyses were per-
formed using GEE.
Results: In total 207 women reported knee pain in one knee at baseline,
460 women reported not having any knee pain at baseline. Finally, 667
women (1334 knees) were included in the analysis with amean age of 53.9
years. In the group of women with unilateral knee pain at baseline, 16.4%
had incident knee pain in the pain-free knee at baseline, in the group of
knee pain-free women at baseline the incidence was 23.0%.
The best predicting determinants for incident knee pain after two years in
all women were: past knee trauma (OR: 1.62, 95% CI: 1.08 - 2.42) and pain
in the other knee at baseline (OR: 2.7, 95% CI: 1.82 - 4.01). In knee pain-free
women at baseline tenderness on palpation of the tibiofemoral joint space
(OR: 3.25, 95% CI: 1.40 - 7.56), past knee trauma (OR: 1.75, 95% CI: 1.02 -
2.99) and lateral meniscus degeneration on MRI (OR: 2.20, 95% CI: 1.02 -
4.73) were the best predictors. Inwomenwith knee pain in one knee these
were: past knee trauma (OR: 2.05, 95% CI: 1.22 - 3.47), being post-
menopausal, (OR: 2.26, 95% CI: 1.08 - 4.71) crepitus on active movement
(OR: 2.07, 95% CI: 1.14 - 3.74) and higher BMI (OR: 1.06, 95% CI: 1.01 - 1.11).
Conclusions: Pain in the other knee and knee trauma were the best
predictors for incident knee pain. In addition, several items from physical
examination were predictive for incident pain two years later, with equal
or higher magnitude than MRI items.
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WEIGHT-BEARING VERSUS NON-WEIGHT-BEARING PAIN. ARE THEY
EQUALLY RELATED TO MRI FINDINGS?
S.P. Verkleij, D. Schiphof, B.W. Koes, A. Hofman, E.H. Oei, H.H. Weinans,
P.A. Luijsterburg, S.M. Bierma-Zeinstra. Erasmus MC, Rotterdam,
Netherlands
Purpose: Pain is the most common complaint reported by patients with
osteoarthritis (OA), but its origin is largely unknown. It is difﬁcult to
measure as it is subjective and different types of pain seem to exist (e.g.
pain on walking, on climbing stairs, on standing, at night, and at rest). It
still remains unclear if these different types are related to
different degenerative changes in the joint. Therefore, the present
